Application of In Vivo microdialysis methods to the study of psychomotor stimulant drugs

Methods in Drug Abuse Research: Cellular and Circuit Level Analyses

Volumn , Issue , 2002, Pages 51-86

  Baumann, Michael H ^a   Rutter, John J ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b TRUMAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057704934     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (56)

1. Robinson, T.E. and Justice, J.B., Jr., Eds., Microdialysis in the Neurosciences, Elsevier, New York, NY, 1991.
2. Bito, R., Davson, H., Levin, E.M., Murray, M., and Snider, N., The concentration of free amino acids and other electrolytes in the cerebrospinal fluid, in vivo dialysate of brain and blood plasma of the dog, J. Neurochem., 13, 1057, 1966.
3. Delgado, J.M.R., De Freudis, F.V., Roth, R.H., Ryugo, D.K., and Mitruka, B.M., Dialytrode for long term intracerebral perfusion in awake monkeys, Arch. Int. Pharmacodyn., 198, 9, 1972.
4. Ungerstedt, U., Measurement of neurotransmitter release by intracranial dialysis, in Measurement of Neurotransmitter Release in Vivo, Marsden, C.A., Ed., John Wiley & Sons, New York, NY, 1984, pp. 81-105.
5. Kissinger, P.T. and Shoup, R.E., Optimization of LC apparatus for determinations in neurochemistry with and emphasis on microdialysis samples, J. Neurosci. Methods, 34, 3, 1990.
6. Mefford, I.N., Biomedical uses of high-performance liquid chromatography with electrochemical detection, Methods Biochem. Anal., 31, 221, 1985.
7. Kendrick, K.M., Microdialysis measurement of in vivo neuropeptide release, J. Neurosci. Methods, 34, 35, 1990.
8. Westerink, B.H.C. and Justice, J.B., Jr., Microdialysis compared with other in vivo release models, Microdialysis in the Neurosciences, Robinson, T.E. and Justice, K.B., Eds., Elsevier, New York, NY, 1991, pp. 23-46.
9. Westerink, B.H. and DeVries, J.B., Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects, J. Neurochem., 51, 683, 1988.
10. Auerbach, S.B., Minzenberg, M.J., and Wilkinson, L.O., Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release, Brain Res., 499, 281, 1989.
11. Moghaddam, B. and Bunney, B.S., Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine, J. Neurochem., 53, 652, 1989.
12. Benveniste, H., Brain microdialysis, J. Neurochem., 52, 1667, 1989.
13. Justice, J.B., Jr., Quantitative microdialysis of neurotransmitters, J. Neurosci. Methods, 48, 263, 1993.
14. Bungay, P.M., Morrison, P.F., and Dedrick, R.L., Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro, Life Sci., 46, 105, 1990.
15. Santiago, M. and Westerink, B.H., Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes, Nauyn Schmiedebergs Arch. Pharmacol., 342, 407, 1990.
16. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, New York, NY, 1986.
17. Hernandez, L., Stanley, B.G., and Hoebel, B.G., A small, removable microdialysis probe, Life Sci., 39, 2629, 1986.
18. Baumann, M.H., Ayestas, M.A., Sharpe, L.G., Lewis, D.B., Rice, K.C., and Rothman, R.B., Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 deconoate, J. Pharmacol. Exp. Ther., 301, 1190, 2002.
19. Rutter, J.J., Baumann, M.H., and Waterhouse, B.D., Systemically administered cocaine alters stimulus-evoked responses of thalamic somatosensory neurons to perithreshold vibrissae stimulation, Brain Res., 798, 7, 1998.
20. Koob, G.F. and Bloom, F.E., Cellular and molecular mechanisms of drug dependence, Science, 242, 715, 1988.
21. Wise, R.A., Neurobiology of addiction, Curr. Opin. Neurobiol., 6, 243, 1996.
22. Hernandez, L. and Hoebel, B.G., Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis, Life Sci., 42, 1705, 1988.
23. DiChiara, G. and Imperato, A., Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats, Proc. Natl. Acad. Sci., 85, 5274, 1988.
24. Robinson, T.E., Jurson, P.A., Bennett, J.A., and Bentgen, K.M., Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats, Brain Res., 462, 211, 1988.
25. Wall, S.C., Gu, H., and Rudnick, G., Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux, Mol. Pharmacol., 47, 544, 1995.
26. Sonders, M.S., Zhu, S.J., Zahniser, N.R., Kavanaugh, M.P., and Amara, S.G., Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants, J. Neurosci., 17, 960, 1997.
27. Baumann, M.H., Char, G.U., DeCosta, B.R., Rice, K.C., and Rothman, R.B., GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat, J. Pharmacol. Exp. Ther., 271, 1216, 1994.
28. Hurd, Y.L., Weiss, F., Koob, G.F., And, N.E., and Ungerstedt, U., Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study, Brain Res., 498, 199, 1989.
29. Pettit, H.O. and Justice, J.B., Jr., Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis, Pharmacol. Biochem. Behav., 34, 899, 1989.
30. Parsons, L.H. and Justice, J.B., Jr., Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration, J. Neurochem., 61, 1611, 1993.
31. Kuczenski, R., Segal, D.S., Cho, A.K., and Melega, W., Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine, J. Neurosci., 15, 1308, 1995.
32. Reith, M.E., Li, M.Y., and Yan, Q.S., Extracellular dopamine, norepinephrine, and serotonin in the ventral tegemental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and uptake blockers, Psychopharmacology, 134, 309, 1997.
33. Rothman, R.B., Partilla, J.S., Dersch, C.M., Carroll, F.I., and Baumann, M.H., Methamphetamine dependence: medication development efforts based on a dual deficit model of stimulant addiction, Ann. N.Y. Acad. Sci., 914, 71, 2000.
34. Koob, G.F. and Le Moal, M., Drug addiction, dysregulation of reward, and allostasis, Neuropsychopharmacology, 24, 97, 2001.
35. Baumann, M.H. and Rothman, R.B., Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans, Biol. Psychiatry, 44, 578, 1998.
36. Markou, A., Kosten, T.R., and Koob, G.F., Neurobiological similarities in depression and drug dependence: a self-medication hypothesis, Neuropsychopharmacology, 18, 135, 1998.
37. Robertson, M.W., Leslie, C.A., and Bennett, J.P., Jr., Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment, Brain Res., 538, 337, 1991.
38. Parsons, L.H., Smith, A.D., and Justice, J.B., Jr., Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine, Synapse, 9, 60, 1991.
39. Rossetti, Z.L., Hmaidan, Y., and Gessa, G.L., Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats, Eur. J. Pharmacol., 221, 227, 1992.
40. Weiss, F., Markou, A., Lorang, M.T., and Koob, G.F., Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited- access self-administration, Brain Res., 593, 314, 1992.
41. Parsons, L.H., Koob, G.F., and Weiss, F., Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine, J. Pharmacol. Exp. Ther., 274, 1182, 1995.
42. Kleven, M.S. and Seiden, L.S., Methamphetamine-induced neurotoxicity: structure activity relationships, Ann. N.Y. Acad. Sci., 654, 292, 1992.
43. Robinson, T.E., Castaneda, E., and Whishaw, I.Q., Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine:a review of evidence from microdialysis studies, Can. J. Psychol., 44, 253, 1990.
44. Cass, W.A., Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine, J. Pharmacol. Exp. Ther., 280, 105, 1997.
45. Cass, W.A. and Manning, M.W., Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine, J. Neurosci., 19, 7653, 1999.
46. Cass, W.A., Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine, J. Neurochem., 74, 1079, 2000.
47. Rothman, R.B., Ayestas, M.A., Dersch, C.M., and Baumann, M.H., Aminorex, fenfluramine, and chlorphenteramine are serotonin transporter substrates. Implications for primary pulmonary hypertension, Circulation, 100, 869, 1999.
48. Baumann, M.H., Ayestas, M.A., Dersch, C.M., and Rothman, R.B., 1-(m-chlorophenyl) piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain, Neuropsychopharmacology, 24, 492, 2001.
49. Rothman, R.B. and Glowa, J.R., A review of the effects of dopaminergic agents on humans, animals, and drug seeking behavior and its implications for medication development: focus on GBR12909, Mol. Neurobiol., 11, 1, 1995.
50. Andersen, P.H., The dopamine uptake inhibitor GBR12909: selectivity and molecular mechanism of action, Eur. J. Pharmacol., 166, 493, 1989.
51. Rothman, R.B., Mele, A., Reid, A.A., Akunne, H.C., Greig, N., Thurkauf, A., DeCosta, B.R., Rice, K.C., and Pert, A., GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine, Pharmacol. Biochem. Behav., 40, 387, 1991.
52. Pogun, S., Scheffel, U., and Kuhar, M.J., Cocaine displaces [3H]WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909, Eur. J. Pharmacol., 198, 203, 1991.
53. Tella, S.R., Effects of monoamine reuptake inhibitors on cocaine self-administration in rats, Pharmacol. Biochem. Behav., 51, 687, 1995.
54. Glowa, J.R., Wojnicki, F.H.E., Matecka, D., Rice, K.C., and Rothman, R.B., Effects of dopamine reuptake inhibitors on food and cocaine maintained responding. II. Comparisons with other drugs and repeated administrations, Exp. Clin. Psychopharmacol., 3, 232, 1995.
55. Lewis, D.B., Matecka, D., Zhang, Y., Hsin, L-W., Dersch, C.M., Stafford, D., Glowa, J.R., Rothman, R.B., and Rice, K.C., Oxygenated analogs of 1-[2-(diphenylmethoxy)- ethyl]- and 1-[2-[bis-(4-fluorophenyl)methoxy]ethyl] 4-(3-phenylpropyl)piperazines (GBR12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents, J. Med. Chem., 42, 5029, 1999.
56. Glowa, J.R., Fantegrossi, W.E., Lewis, D.B., Matecka, D., Rice, K.C., and Rothman, R.B., Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis-(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate, a long-acting ester derivative of GBR 12909, J. Med. Chem., 39, 4689, 1996.